Skip to content
Disclosery

Lion Point Capital, LP

Follow

13F filer, CIK 1643354, NEW YORK, NY

Lion Point Capital, LP reported $19,099,206 across 19 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14. Its ten largest share positions make up 74.76% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-25-000268

The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.

Period
2024-12-31
Reported value
$19.1M
Holdings
19
Top 10 weight
74.76%
New
1
Sold out
7

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BLUEBIRD BIO INC COM NEWnew+78,912$658K
BNTCadded+23,000$290K
IRONadded+2,900$184K
ARQTadded+11,200$156K
SNDXadded+8,800$116K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MISTreduced-628,348-$1.48M
MARINUS PHARMACEUTICALS INCexited-693,778-$1.22M
INSMreduced-15,500-$1.07M
BLUEBIRD BIO INCexited-1,578,256-$820K
BHVNreduced-12,700-$474K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001013594-25-000268, largest first. % of portfolio is the value over $19,099,206, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 52,200 shares; 2024Q4: 36,700 shares 36,700$2.53M13.27%-15,500The filing omitted confidential holdings, a later amendment may add them.Timeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,654,154 shares; 2024Q4: 1,025,806 shares 1,025,806$2.42M12.68%-628,348The filing omitted confidential holdings, a later amendment may add them.Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 630,000 shares; 2024Q4: 500,000 shares 500,000$1.77M9.27%-130,000The filing omitted confidential holdings, a later amendment may add them.Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 370,000 shares; 2024Q4: 335,400 shares 335,400$1.7M8.9%-34,600The filing omitted confidential holdings, a later amendment may add them.Timeline
FENCFENNEC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 215,000 shares; 2024Q4: 195,700 shares 195,700$1.24M6.48%-19,300The filing omitted confidential holdings, a later amendment may add them.Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 49,000 shares; 2024Q4: 40,300 shares 40,300$1.11M5.79%-8,700The filing omitted confidential holdings, a later amendment may add them.Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 79,000 shares; 2024Q4: 79,000 shares 79,000$972K5.09%0The filing omitted confidential holdings, a later amendment may add them.Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 61,400 shares; 2024Q4: 45,900 shares 45,900$908K4.75%-15,500The filing omitted confidential holdings, a later amendment may add them.Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,400 shares; 2024Q4: 22,700 shares 22,700$848K4.44%-12,700The filing omitted confidential holdings, a later amendment may add them.Timeline
BNTCBENITEC BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 39,000 shares; 2024Q4: 62,000 shares 62,000$783K4.1%+23,000The filing omitted confidential holdings, a later amendment may add them.Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 46,200 shares; 2024Q4: 55,000 shares 55,000$727K3.81%+8,800The filing omitted confidential holdings, a later amendment may add them.Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 32,000 shares; 2024Q4: 32,000 shares 32,000$684K3.58%0The filing omitted confidential holdings, a later amendment may add them.Timeline
AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,000 shares; 2024Q4: 64,000 shares 64,000$673K3.52%0The filing omitted confidential holdings, a later amendment may add them.
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,700 shares; 2024Q4: 10,600 shares 10,600$672K3.52%+2,900The filing omitted confidential holdings, a later amendment may add them.Timeline
BLUEBIRD BIO INC COM NEWBLUEBIRD BIO INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 78,912 shares 78,912$658K3.45%newThe filing omitted confidential holdings, a later amendment may add them.
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,100 shares; 2024Q4: 46,300 shares 46,300$645K3.38%+11,200The filing omitted confidential holdings, a later amendment may add them.Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 57,750 shares; 2024Q4: 57,750 shares 57,750$446K2.34%0The filing omitted confidential holdings, a later amendment may add them.Timeline
SERES THERAPEUTICS INCSERES THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 340,761 shares; 2024Q4: 340,761 shares 340,761$283K1.48%0The filing omitted confidential holdings, a later amendment may add them.
SPRUCE BIOSCIENCES INCSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 75,000 shares; 2024Q4: 75,000 shares 75,000$31.5K0.16%0The filing omitted confidential holdings, a later amendment may add them.

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IWMISHARES TR82,500$18.2Mput
MIRMMIRUM PHARMACEUTICALS INC45,000$1.75Mput
MARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INC693,778$1.22Mshares
BLUEBIRD BIO INCBLUEBIRD BIO INC1,578,256$820Kshares
LUMOS PHARMA INCLUMOS PHARMA INC39,589$153Kshares
MSFTMICROSOFT CORP100$43Kshares
GOOGALPHABET INC100$16.7Kshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001013594-25-000268 base2025-02-14acceptance time not in the bulk data set